UM

Browse/Search Results:  1-4 of 4 Help

Selected(0)Clear Items/Page:    Sort:
Downregulation of Cyclin B1 mediates nagilactone E-induced G2 phase cell cycle arrest in non-small cell lung cancer cells Journal article
EUROPEAN JOURNAL OF PHARMACOLOGY, 2018,Volume: 830,Page: 17-25
Authors:  Zhang, Le-Le;  Feng, Zhe-Ling;  Su, Min-Xia;  Jiang, Xiao-Ming;  Chen, Xiuping;  Wang, Yitao;  Li, Ao;  Lin, Li-Gen;  Lu, Jin-Jian
View  |  Adobe PDF(3226Kb)  |  Favorite  |  View/Download:122/16  |  Submit date:2018/10/30
Nagilactone e  Non-small Cell Lung Cancer  Cyclin B1  Cell Cycle  Apoptosis  
Osimertinib (AZD9291) decreases programmed death ligand-1 in EGFR-mutated non-small cell lung cancer cells Journal article
ACTA PHARMACOLOGICA SINICA, 2017,Volume: 38,Issue: 11,Page: 1512-1520
Authors:  Jiang, Xiao-Ming;  Xu, Yu-Lian;  Huang, Mu-Yang;  Zhang, Le-Le;  Su, Min-Xia;  Chen, Xiuping;  Lu, Jin-Jian
Favorite  |  View/Download:13/0  |  Submit date:2018/10/30
Non-small Cell Lung Cancer  Egfr  Osimertinib  Pd-l1  Ubiquitin-proteasome System  Mg-132  Bortezomib  Gsk3 Beta  Licl  
Synergistic effect of fenretinide and curcumin for treatment of non-small cell lung cancer Journal article
Cancer Biology and Therapy, 2016,Volume: 17,Issue: 10,Page: 1022-1029
Authors:  Chen H.;  Chen L.;  Wang L.;  Zhou X.;  Chan J.Y.-W.;  Li J.;  Cui G.;  Lee S.M.-Y.
Favorite  |  View/Download:4/0  |  Submit date:2018/11/06
Curcumin  fenretinide  GRP78  non-small cell lung cancer  
Combined effect of genetic polymorphisms in P53, P73, and MDM2 on non-small cell lung cancer survival Journal article
Journal of Thoracic Oncology, 2011,Volume: 6,Issue: 11,Page: 1793-1800
Authors:  Liu L.;  Wu C.;  Wang Y.;  Zhong R.;  Duan S.;  Wei S.;  Lin S.;  Zhang X.;  Tan W.;  Yu D.;  Nie S.;  Miao X.;  Lin D.
Favorite  |  View/Download:2/0  |  Submit date:2019/01/16
MDM2  Non-small cell lung cancer  P53  P73  Survival